Jeff Yass’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-42,900
| Closed | -$243K | – | 13472 |
|
|
2025
Q3 | $243K | Sell |
42,900
-98,500
| -70% | -$504K | ﹤0.01% | 10577 |
|
|
2025
Q2 | $539K | Buy |
141,400
+59,400
| +72% | +$184K | ﹤0.01% | 9008 |
|
|
2025
Q1 | $216K | Sell |
82,000
-18,400
| -18% | -$59.9K | ﹤0.01% | 10790 |
|
|
2024
Q4 | $355K | Buy |
100,400
+10,800
| +12% | +$41.4K | ﹤0.01% | 9455 |
|
|
2024
Q3 | $409K | Buy |
89,600
+77,700
| +653% | +$376K | ﹤0.01% | 8955 |
|
|
2024
Q2 | $51.8K | Sell |
11,900
-3,200
| -21% | -$14.1K | ﹤0.01% | 11400 |
|
|
2024
Q1 | $75.8K | Sell |
15,100
-500
| -3% | -$2.8K | ﹤0.01% | 11361 |
|
|
2023
Q4 | $97.8K | Sell |
15,600
-37,300
| -71% | -$214K | ﹤0.01% | 11351 |
|
|
2023
Q3 | $377K | Buy |
52,900
+36,300
| +219% | +$286K | ﹤0.01% | 8871 |
|
|
2023
Q2 | $169K | Sell |
16,600
-5,100
| -24% | -$53.2K | ﹤0.01% | 10450 |
|
|
2023
Q1 | $197K | Buy |
21,700
+6,700
| +45% | +$49.1K | ﹤0.01% | 10613 |
|
|
2022
Q4 | $108K | Buy |
+15,000
| New | +$91.6K | ﹤0.01% | 10904 |
|
Jeff Yass's SCPH Position: Q3 2025 in Review
Jeff Yass sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 138,460 shares — an estimated $709K sold.
Jeff Yass first reported a position in SCPH in Q4 2018 and held it in 16 quarters. The position peaked at $2.06M in Q1 2023. 110 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.
- Jeff Yass reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
- Jeff Yass sold 138,460 scPharmaceuticals shares in Q3 2025, an estimated $709K.
- Jeff Yass first reported a position in scPharmaceuticals in Q4 2018 and held it in 16 quarters.
- Jeff Yass's scPharmaceuticals position peaked at $2.06M in Q1 2023.
- 110 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.